Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine
NCT05005247
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Group B Streptococcus Infection
Interventions
BIOLOGICAL:
GBS-NN/NN2
Sponsor
Minervax ApS